Evidence map›Paper›PMID 29633596›Full record

ArticleCell journal2018

Promoter Methylation Status of Survival-Related Genes in MOLT- 4 Cells Co-Cultured with Bone Marrow Mesenchymal Stem Cells under Hypoxic Conditions.

Milad Ahani-Nahayati, Saeed Solali, Karim Shams Asenjan, Ali Akbar Movassaghpour Akbari, Mehdi Talebi, Milad Zadi Heydarabad, Sina Baharaghdam, Majid Farshdousti Hagh

Open access · greenAbstract read
In one paragraph

Article in Cell journal, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed
0.7field-weighted citation impact, top 34% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed, 12 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Review
  7. Article
  8. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 1 institution in 1 country.

Milad Ahani-NahayatiImmunology Research Center, Tabriz University of Medical Sciences, Tabriz, Iran.
Saeed SolaliImmunology Research Center, Tabriz University of Medical Sciences, Tabriz, Iran.
Karim Shams AsenjanDrug Applied Research Center (DARC), Tabriz University of Medical Sciences, Tabriz, Iran.
Ali Akbar Movassaghpour AkbariHematology and Oncology Research Center, Tabriz University of Medical Sciences, Tabriz, Iran.
Mehdi TalebiImmunology Research Center, Tabriz University of Medical Sciences, Tabriz, Iran.
Milad Zadi HeydarabadImmunology Research Center, Tabriz University of Medical Sciences, Tabriz, Iran.
Sina BaharaghdamImmunology Research Center, Tabriz University of Medical Sciences, Tabriz, Iran.
Majid Farshdousti HaghImmunology Research Center, Tabriz University of Medical Sciences, Tabriz, Iran. Electronic address: farshdoustim@tbzmed.ac.ir.
Tabriz University of Medical Sciences · IR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

objectivesDNA methylation is a well-studied epigenetic mechanism that is a potent arm of the gene expression controlling machinery. Since the hypoxic situation and the various cells of bone marrow microenvironment, e.g. mesenchymal stem cells, play a role in the in vivo and in vitro biology of leukemic cells, we decided to study the effects of hypoxia and mesenchymal stem cells (MSCs) on the promoter methylation pattern of BAX and BCL2 genes. MATERIALS AND

methodsIn this experimental study, the co-culture of MOLT-4 cells with MSCs and treatment with CoCl

resultsThe BAX and BCL2 promoters of untreated MOLT-4 cells were in partial methylated and fully unmethylated states, respectively. After incubating the cancer cells with CoCl

conclusionsHypoxia and MSCs actually have no notable effect on the methylation status of the promoters of BAX and BCL2 in the specifically studied regions. DNA methylation is probably not the main process by which MSCs and CoCl

Indexed as

Acute Lymphoblastic LeukemiaDNA MethylationMesenchymal Stem CellPromoter Regions

Identifiers

PMID29633596
PMCPMC5893290
OpenAlexW3023226075

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.